CELSR2 and central nervous system cancer: After CELSR2 was knocked down by CELSR2-shRNA, proliferation of glioma growth was significantly downregulated as shown by EDU labelling, and cell cycle of growing glioma was arrested as shown by an increase of G0/G1 ratio and a decrease of S phase.